05/18/2025
11:15 PM | Tyra Biosciences (Filer)
| Form EFFECT | |
05/14/2025
10:47 AM | JANUS HENDERSON GROUP PLC (Filed by)
Tyra Biosciences (Subject)
| Form SCHEDULE 13G | |
05/12/2025
9:43 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SCHEDULE 13G/A | |
05/08/2025
3:30 PM | Tyra Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/31/2025
3:54 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
| Form SCHEDULE 13D/A | |
03/18/2025
5:44 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:44 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
5:02 PM | TCG Crossover GP I, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SCHEDULE 13G | |
02/07/2025
3:43 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
4:42 PM | Canaan XI L.P. (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
3:41 PM | Canaan 2020+ Co-Investment L.P. Series 7 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for TYRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tyra Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
01/27/2025
4:09 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:00 PM | Subramony Siddarth (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
4:47 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
4:42 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
8:30 PM | Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
12/05/2024
3:21 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
6:06 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:47 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:31 PM | Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
11/14/2024
4:52 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:47 PM | NEXTECH VI ONCOLOGY SCSP (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/14/2024
3:34 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/13/2024
5:04 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/08/2024
3:43 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
6:24 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
5:18 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:22 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
4:15 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/28/2024
6:00 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
7:01 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
8:15 PM | Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/22/2024
7:47 PM | Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:49 PM | Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
4:11 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/22/2024
4:13 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
4:04 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:23 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:12 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
4:51 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
10/15/2024
8:59 PM | Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/15/2024
6:22 PM | Boxer Asset Management Inc. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/02/2024
4:38 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
5:44 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
5:24 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:49 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:42 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
2:56 PM | Harris Irrevocable Trust 2 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
2:59 PM | Harris Irrevocable Trust 3 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:05 PM | Harris Irrevocable Trust 4 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
2:27 PM | Harris Irrevocable Trust 1 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024
4:12 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:15 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:49 PM | Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/10/2024
3:53 PM | Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:50 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:55 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:18 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:10 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
2:08 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
5:26 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | MORE ROBERT J (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | KAPLAN GILLA (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Subramony Siddarth (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Tyra Biosciences (Issuer)
Verjee Rehan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Simson Jake (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy TYRA Stock Free TYRA Stock Alerts